Intracoronary brachytherapy

Catheterization and Cardiovascular Interventions

Volumn 56, Issue 2, 2002, Pages 281-288

  Nguyen Ho, Phong ^a   Kaluza, Grzegorz L ^a   Zymek, Pawel T ^a   Raizner, Albert E ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Angioplasty; Brachytherapy; Coronary; Restenosis; Stent

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; PYRIDINE;

ACUTE HEART INFARCTION; BRACHYTHERAPY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; FOOD AND DRUG ADMINISTRATION; GAMMA RADIATION; HUMAN; RESTENOSIS; REVIEW; TREATMENT CONTRAINDICATION;

BETA RAYS; BRACHYTHERAPY; CORONARY RESTENOSIS; CORONARY VESSELS; GAMMA RAYS; HUMANS; RECURRENCE; RETREATMENT; STENTS;

EID: 0036266946     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10260     Document Type: Review

References (33)

1. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome
2. Geometric vascular remodeling after balloon angioplasty and beta- radiation therapy: A three-dimensional intravascular ultrasound study
3. Radiation
4. The role of the adventitia in the arterial response to angioplasty: The effect of intravascular radiation
5. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries
6. Cellular and molecular mechanisms of radiation inhibition of restenosis: I, role of the macrophage and platelet-derived growth factor
7. Adventitial cells do not contribute to neointimal mass after balloon angioplasty of the rat common carotid artery
8. Basic science review: Radiotherapy for prevention of restenosis
9. New frontiers in interventional cardiology: Intravascular radiation to prevent restenosis
10. Debate: Centering is important
11. The centring debate: The importance of centring in endovascular brachytherapy
12. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents
13. European high-activity 32P radioactive stent experience
14. Radioactive stents delay but do not prevent in-stent neointimal hyperplasia
15. Catheter-based radiotherapy to inhibit restenosis after coronary stenting
16. Three-year clinical and angiographic follow-up after intracoronary radiation: Results of a randomized clinical trial
17. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis
18. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting
19. Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy trial (PREVENT)
20. Use of localized intracoronary beta radiation in treatment of in-stent restenosis: The INHIBIT randomized controlled trial
21. 90Yttrium beta radiation versus placebo for the treatment of in-stent restenosis
22. Late coronary occlusion after intracoronary brachytherapy
23. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis
24. Late thrombosis after coronary radiation may be eliminated by longer antiplatelet therapy and reduced stenting: The SCRIPPS III results
25. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial Plus 6 Months of Clopidogrel (WRIST PLUS)
26. Geographic miss: A cause of treatment failure in radio-oncology applied to intracoronary radiation therapy
27. Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis
28. Five year clinical and angiographic follow-up after intracoronary 192-Iridium radiation therapy
29. Images in cardiology: "Late-late" reocclusion after coronary stenting and brachytherapy
30. A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting trial
31. Effects of 90Sr/90Y beta radiation on diabetic patients with in-stent restenosis
32. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study
33. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up